EUVIMEDEUVIMED entdecken
Crossref

Prescription Testosterone Increases the Risk of Reoperation for Infection and All-Cause Reoperation after Primary Total Knee Arthroplasty

Gloria Coden iD, Hannah I Travers iD, Mikhail Kuznetsov, Jacob Kirsch, James V Bono, Eric L Smith iD

The Journal of Knee Surgery · 01.10.2025 · 38 (12) · 617-625

DOI: 10.1055/a-2608-0156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Knee Surgery, erschienen am 01.10.2025. Verfasst von Gloria Coden und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, New England Baptist Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Testosterone, Reoperation, Arthroplasty, Replacement, Knee, Prosthesis-Related Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rate of total knee arthroplasty (TKA) continues to rise, and with it, the need to identify risk factors for reoperation. Additionally, supplemental testosterone use in male patients has increased across the United States. As more patients taking prescription testosterone replacement therapy (TRT) undergo TKA, there is a need to evaluate TRT as it relates to outcomes following TKA. This study aims to evaluate whether the prescription of supplemental testosterone is a risk factor for reoperation and reoperation for infection following TKA. A retrospective cohort study using a nationwide commercial claims database was conducted. About 76,276 male patients who underwent TKA were identified with a 1.9-year mean follow-up. Reoperations and reoperations for infections were identified using the International Classification of Diseases Tenth Edition (ICD-10) and the Current Procedural Terminology (CPT) codes. Patients were matched based on demographic, geographic, and comorbidities data using Mahalanobis nearest neighbor matching. Statistical analysis was conducted on 3,209 male patients prescribed testosterone and 32,090 not prescribed testosterone. Demographic and comorbidities, including age, location of TKA, length of stay, history of diabetes mellitus, hypertension, hyperlipidemia, obesity, smoking, alcohol, and Charlson Comorbidity Index (CCI) score, were similar (p > 0.05) between male patients prescribed testosterone and men who were not. Men prescribed testosterone had a significantly higher cumulative incidence of reoperation for infection than patients not prescribed testosterone at 1 (p = 0.01), 2 (p < 0.001), 3 (p < 0.001), 4 (p < 0.001), and 5 years postoperatively (p < 0.001). Men prescribed testosterone had a significantly higher cumulative incidence for all-cause reoperation than patients not prescribed testosterone at 1 (p = 0.01), 2 (p = 0.003), 3 (p = 0.01), 4 (p < 0.001), and 5 years postoperatively (p < 0.001). Male patients who were prescribed supplemental testosterone within 1 year prior to primary TKA were at an increased risk for both all-cause reoperation and reoperation due to infection. Surgeons should consider the risks and benefits of testosterone cessation in the perioperative period for patients undergoing TKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneReoperationArthroplasty, Replacement, KneeProsthesis-Related InfectionsHumansMaleRetrospective StudiesAgedMiddle AgedRisk Factors

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, New England Baptist Hospital, Boston, Massachusetts.
  • Division of Physical Medicine and Rehabilitation, Washington University School of Medicine, St. Louis, Missouri.

ORCID-Profile: Gloria Coden, Hannah I Travers, Eric L Smith

Zitieren

APA

Coden, G., Travers, H. I., Kuznetsov, M., Kirsch, J., Bono, J. V., & Smith, E. L. (2025). Prescription Testosterone Increases the Risk of Reoperation for Infection and All-Cause Reoperation after Primary Total Knee Arthroplasty. The Journal of Knee Surgery, 38(12), 617-625. https://doi.org/10.1055/a-2608-0156

Vancouver

Coden G, Travers HI, Kuznetsov M, Kirsch J, Bono JV, Smith EL. Prescription Testosterone Increases the Risk of Reoperation for Infection and All-Cause Reoperation after Primary Total Knee Arthroplasty. The Journal of Knee Surgery. 2025;38(12):617-625. doi:10.1055/a-2608-0156

BibTeX
@article{Coden2025,
  author = {Coden, Gloria and Travers, Hannah I and Kuznetsov, Mikhail and Kirsch, Jacob and Bono, James V and Smith, Eric L},
  title = {Prescription Testosterone Increases the Risk of Reoperation for Infection and All-Cause Reoperation after Primary Total Knee Arthroplasty},
  journal = {The Journal of Knee Surgery},
  year = {2025},
  volume = {38},
  number = {12},
  pages = {617--625},
  doi = {10.1055/a-2608-0156}
}
Kostenlos starten →